Science and Technology Science and Technology
Mon, February 13, 2012
Sun, February 12, 2012
Sat, February 11, 2012
Fri, February 10, 2012

Fluidigm Moves up the Timing of Its Fourth Quarter/Full Year 2011 Financial Results Conference Call


Published on 2012-02-10 10:26:46 - Market Wire
  Print publication without navigation


SOUTH SAN FRANCISCO, Calif.--([ ])--Fluidigm Corporation (NASDAQ:FLDM) will move the timing of its conference call with investors to start at 1:30 p.m. PST (4:30 p.m. EST) on February 14, 2012.

The company will report its fourth quarter and 2011 full year financial results on February 14, 2012, at close of market.

Fluidigm President and Chief Executive Officer Gajus Worthington, and Chief Financial Officer Vikram Jog, will host a conference call at 1:30 p.m. PST (4:30 p.m. EST) on February 14, 2012, to discuss fourth quarter and 2011 full year financial results and operating activities. A press release outlining the financial results will be publicly distributed prior to the call.

The Fluidigm conference call can be accessed by calling (877) 556-5248 (domestic toll-free) or (720) 545-0029 (international toll). There will be a Q&A period during the call.

Fluidigm will also provide a live stream of its fourth quarter and 2011 full year financial results conference call for investors at: [ http://investors.fluidigm.com/events.cfm ]. The link will not be active until 1:15 p.m. PST on February 14, 2012. A telephone replay of the teleconference will be available 90 minutes after the end of the call at (855) 859-2056 (domestic toll-free), or (404) 537-3406 (international toll), access code 48648892. The conference call will also be archived on the Fluidigm investoras page at: [ http://investors.fluidigm.com ].

About Fluidigm

Fluidigm (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigmas proprietary microfluidic systems consist of instruments and consumables, including chips, assays and other reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets three microfluidic systems, including eight different commercial chips, to leading pharmaceutical and biotechnology companies, academic institutions and Ag-Bio companies.

For more information, please visit [ www.fluidigm.com ].

Fluidigm and the Fluidigm logo, are trademarks or registered trademarks of Fluidigm Corporation.

Contributing Sources